135 related articles for article (PubMed ID: 9264277)
1. Transforming growth factor alpha distribution in rectal crypts as a biomarker of decreased colon cancer risk in patients consuming cellulose.
Hardman WE; Cameron IL; Beer WH; Speeg KV; Kadakia SC; Lang KA
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):633-7. PubMed ID: 9264277
[TBL] [Abstract][Full Text] [Related]
2. The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps.
Alberts DS; Einspahr J; Ritenbaugh C; Aickin M; Rees-McGee S; Atwood J; Emerson S; Mason-Liddil N; Bettinger L; Patel J; Bellapravalu S; Ramanujam PS; Phelps J; Clark L
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):161-9. PubMed ID: 9138658
[TBL] [Abstract][Full Text] [Related]
3. Effect of aspirin on prostaglandin E2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon.
Barnes CJ; Hamby-Mason RL; Hardman WE; Cameron IL; Speeg KV; Lee M
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):311-5. PubMed ID: 10207634
[TBL] [Abstract][Full Text] [Related]
4. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
5. The polyp prevention trial continued follow-up study: no effect of a low-fat, high-fiber, high-fruit, and -vegetable diet on adenoma recurrence eight years after randomization.
Lanza E; Yu B; Murphy G; Albert PS; Caan B; Marshall JR; Lance P; Paskett ED; Weissfeld J; Slattery M; Burt R; Iber F; Shike M; Kikendall JW; Brewer BK; Schatzkin A;
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1745-52. PubMed ID: 17855692
[TBL] [Abstract][Full Text] [Related]
6. Rectal mucosal proliferation and risk of colorectal adenomas: results from a randomized controlled trial.
Sandler RS; Baron JA; Tosteson TD; Mandel JS; Haile RW
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):653-6. PubMed ID: 10919733
[TBL] [Abstract][Full Text] [Related]
7. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers in colorectal cancer.
Owen RW
IARC Sci Publ; 2001; 154():101-11. PubMed ID: 11220650
[TBL] [Abstract][Full Text] [Related]
9. Reliability of rectal epithelial kinetic patterns as an intermediate biomarker of colon cancer.
Anti M; Marra G; Percesepe A; Armelao F; Gasbarrini G
J Cell Biochem Suppl; 1994; 19():68-75. PubMed ID: 7823608
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistry.
Lyles CM; Sandler RS; Keku TO; Kupper LL; Millikan RC; Murray SC; Bangdiwala SI; Ulshen MH
Cancer Epidemiol Biomarkers Prev; 1994; 3(7):597-605. PubMed ID: 7827591
[TBL] [Abstract][Full Text] [Related]
11. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
12. Crypt-restricted loss and decreased protein expression of cytochrome C oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk.
Payne CM; Holubec H; Bernstein C; Bernstein H; Dvorak K; Green SB; Wilson M; Dall'Agnol M; Dvorakova B; Warneke J; Garewal H
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2066-75. PubMed ID: 16172211
[TBL] [Abstract][Full Text] [Related]
13. Intermediate effect markers for colorectal cancer.
Baron JA
IARC Sci Publ; 2001; 154():113-29. PubMed ID: 11220651
[TBL] [Abstract][Full Text] [Related]
14. Comparison of malignant potential between serrated adenomas and traditional adenomas.
Song SY; Kim YH; Yu MK; Kim JH; Lee JM; Son HJ; Rhee PL; Kim JJ; Paik SW; Rhee JC
J Gastroenterol Hepatol; 2007 Nov; 22(11):1786-90. PubMed ID: 17914951
[TBL] [Abstract][Full Text] [Related]
15. Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients.
Bostick RM; Fosdick L; Grandits GA; Lillemoe TJ; Wood JR; Grambsch P; Louis TA; Potter JD
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1011-9. PubMed ID: 9419396
[TBL] [Abstract][Full Text] [Related]
16. [Colonic polyps: clinical and practical implications].
Bühler H
Ther Umsch; 1991 Jul; 48(7):440-4. PubMed ID: 1926002
[TBL] [Abstract][Full Text] [Related]
17. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
[TBL] [Abstract][Full Text] [Related]
18. A dietary trial with a short-term low-sucrose diet in an Italian population: effects on colorectal mucosal proliferation.
Caderni G; Lancioni L; Palli D; Saieva C; Trallori G; Manneschi L; Renai F; Marcoccia M; Russo A; Dolara P
Nutr Cancer; 1998; 32(3):159-64. PubMed ID: 10050266
[TBL] [Abstract][Full Text] [Related]
19. Intake of supplemental and total fiber and risk of colorectal adenoma recurrence in the wheat bran fiber trial.
Jacobs ET; Giuliano AR; Roe DJ; Guillén-Rodríguez JM; Hess LM; Alberts DS; Martínez ME
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):906-14. PubMed ID: 12223437
[TBL] [Abstract][Full Text] [Related]
20. Calcium and colorectal epithelial cell proliferation in ulcerative colitis.
Bostick RM; Boldt M; Darif M; Wood JR; Overn P; Potter JD
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1021-7. PubMed ID: 9419397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
